Scientists developed a molecule treatment method for Parkinson’s disease. The molecule therapy can inhibit mutations in LRRK2 (leucine-rich repeat kinase 2 ), a gene linked to lysosomal malfunction and Parkinson’s disease – #Future

your username

your password